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Abstract
Expanded trinucleotide repeat sequences are the cause of several inherited neurodegenerative diseases. Disease
pathogenesis is correlated with several features of somatic instability of these sequences, including further large expansions
in postmitotic tissues. The presence of somatic expansions in postmitotic tissues is consistent with DNA repair being a major
determinant of somatic instability. Indeed, proteins in the mismatch repair (MMR) pathway are required for instability of the
expanded (CAG?CTG)n sequence, likely via recognition of intrastrand hairpins by MutSb. It is not clear if or how MMR would
affect instability of disease-causing expanded trinucleotide repeat sequences that adopt secondary structures other than
hairpins, such as the triplex/R-loop forming (GAA?TTC)n sequence that causes Friedreich ataxia. We analyzed somatic
instability in transgenic mice that carry an expanded (GAA?TTC)n sequence in the context of the human FXN locus and lack
the individual MMR proteins Msh2, Msh6 or Pms2. The absence of Msh2 or Msh6 resulted in a dramatic reduction in somatic
mutations, indicating that mammalian MMR promotes instability of the (GAA?TTC)n sequence via MutSa. The absence of
Pms2 resulted in increased accumulation of large expansions in the nervous system (cerebellum, cerebrum, and dorsal root
ganglia) but not in non-neuronal tissues (heart and kidney), without affecting the prevalence of contractions. Pms2
suppressed large expansions specifically in tissues showing MutSa-dependent somatic instability, suggesting that they may
act on the same lesion or structure associated with the expanded (GAA?TTC)n sequence. We conclude that Pms2 specifically
suppresses large expansions of a pathogenic trinucleotide repeat sequence in neuronal tissues, possibly acting
independently of the canonical MMR pathway.
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Introduction
Expanded trinucleotide repeat sequences are known to cause
several inherited human neurodegenerative diseases [1]. These
sequences are subject to changes in repeat length during parental
transmission, a phenomenon termed intergenerational instability.
In addition, expanded trinucleotide repeats undergo further large
expansions in specific somatic tissues. Although both forms of
instability appear to influence disease onset and progression, it is
likely that intergenerational and somatic instability occur by
distinct mechanisms. This report focuses specifically on uncovering
the processes that influence somatic instability.
Several observations indicate that somatic instability resulting in
progressive expansion within specific tissues contributes to disease
pathogenesis and progression. First, the tissue-specificity of somatic
instability tends to correlate with disease pathology. For example,
in Huntington disease and myotonic dystrophy the expanded
(CAG?CTG)n sequence undergoes further large expansions in the
striatum and muscle, respectively [2,3]. Similarly, in Friedreich
ataxia (FRDA), the pathogenic expanded (GAA?TTC)n sequence
in intron 1 of the FXN gene [4] undergoes progressive expansion in
the cerebellum and dorsal root ganglia of FRDA patients [5] and
in a transgenic mouse model [6]. Second, somatic instability is
known to precede the development of the disease phenotype in a
mouse model of Huntington disease [2,3,7]. Finally, the absence of
somatic instability can ameliorate the disease phenotype. Genetic
suppression of somatic instability in a mouse model for
Huntington disease significantly delayed intracellular accumula-
tion of mutant huntingtin protein, the onset of disease, and death
[8]. Likewise, somatic instability seems to be important in the
pathology of FRDA. In transgenic mice, an expanded
(GAA?TTC)n sequence within a human FXN transgene recapit-
ulated the age-dependent and tissue-specific somatic instability
observed in FRDA patients [6], and rescuing the embryonic-lethal
Fxn-deficient mice with this transgene resulted in an FRDA-like
phenotype [9,10]. However, when a similar-sized (GAA?TTC)n
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repeat was knocked-in into the mouse Fxn gene, the sequence did
not show somatic instability, and it was not possible to replicate the
FRDA phenotype [11]. Furthermore, an expanded (GAA?TTC)n
sequence in an intron of the At4g13430 gene was found to cause a
growth defect in Arabidopsis thaliana, and this repeat also displayed
somatic instability [12]. Therefore, understanding the molecular
mechanisms of somatic instability of disease-causing expanded
trinucleotide repeats in somatic tissues is of great interest.
The post-mitotic nature of tissues affected in trinucleotide
expansion disorders indicates that DNA repair may be an
important determinant of somatic instability. The highly con-
served mismatch repair (MMR) system prevents point mutations,
insertions and deletions. In Escherichia coli, MMR is initiated when
a MutS homodimer recognizes and binds a mismatch or insertion-
deletion loop (IDL) [13]. Mismatch binding stimulates ATP
hydrolysis by MutS, which is required for progression of MMR. A
MutL homodimer is recruited, and the MutS-MutL complex
activates the latent endonuclease activity of MutH. The bases from
the nick to the mispaired base(s) are excised and re-synthesized to
repair the lesion. Mammalian MMR is initiated by a heterodimer
of the MutS homologs Msh2, Msh3 and Msh6 [14]. MutSa
(Msh2-Msh6) preferentially recognizes base-base mispairs and
IDLs of one to two bases, while MutSb (Msh2-Msh3) preferentially
recognizes IDLs of two to ten bases. The mammalian MutL
homologs Mlh1, Mlh3 and Pms2 also function as heterodimers.
The primary MutL heterodimer, MutLa (Mlh1-Pms2), can be
recruited by either MutSa or MutSb. MutLc (Mlh1-Mlh3) may be
recruited by MutSa, but the role of MutLc in MMR is unclear.
There is no known mammalian MutH homolog, although there is
evidence to suggest that Pms2 can function as an endonuclease
[15,16].
MMR deficiency causes microsatellite instability, a form of
genomic instability characterized by widespread somatic length
variability in short tandem repeats, typically involving few repeat
units. Consistent with this role, MMR is known to prevent small
length changes of expanded trinucleotide repeats [17]. However,
proteins in the MMR pathway have been shown to promote large
length changes of expanded (CAG?CTG)n sequences. In mice, the
absence of Msh2 or Msh3 was shown to eliminate somatic
expansions of (CAG?CTG)n [7,18–22]. The absence of Msh6 did
not reduce the frequency of somatic expansions in neuronal
tissues, although it may affect instability in other tissues [20,22].
These results indicate that MutSb is required to produce somatic
expansions of the expanded (CAG?CTG)n sequence, and multiple
lines of evidence suggest that somatic expansions occur through
the MMR pathway itself. First, MutSb promotes repair on CAG/
CTG hairpin templates in vitro [23]. In addition, in mice lacking
Pms2, the rate of somatic expansions of the expanded
(CAG?CTG)n sequence was reduced by ,50% [24]. Finally,
expansions were eliminated in mice homozygous for an ATPase-
deficient mutation of Msh2 [25]. These data indicate involvement
of the downstream steps of MMR and support the role of an
intact, but error-prone, MMR pathway in producing somatic
expansions of the (CAG?CTG)n sequence. However, it has also
been proposed that MutSb could produce expansions by acting
independently of the other MMR proteins to create CAG/CTG
hairpins or prevent their repair [26–28]. Indeed, many MMR
proteins are known to have functions outside of the canonical
MMR pathway; the mammalian MutS and MutL homologs are
known to play important roles in processes such as class switch
recombination, homologous recombination and DNA damage
signaling [13–17]. Thus, it is possible that MMR proteins could
act through various DNA modifying pathways to influence somatic
instability.
The accuracy and efficiency of DNA repair, and which repair
pathway(s) are activated, are in turn affected by the DNA sequence
and structure [29–32]. Therefore, the effect of MMR proteins on
trinucleotide repeat instability could vary depending on the
sequence of the repeat motif and its secondary structure(s). While
the (CAG?CTG)n sequence forms intrastrand hairpins [33,34], the
(GAA?TTC)n sequence tends to form triplex-based structures [35–
40]. In yeast, MutSb and MutLa promote fragility of expanded
(GAA?TTC)n sequences, leading to large deletions within the
repeat tract [41]. However, the role of mammalian MMR proteins
in tissue-specific expansions of the (GAA?TTC)n sequence remains
unclear.
To determine if and how MMR proteins affect instability of the
(GAA?TTC)n sequence in the context of mammalian tissues, we
crossed the previously described YG8 transgenic mouse model
[6,42] with mice lacking the individual MMR proteins Msh2,
Msh6, or Pms2 [43–45] and analyzed somatic instability by small-
pool PCR [46]. Absence of Msh2 or Msh6 significantly stabilized
the repeat tract. Remarkably, Pms2 deficiency increased the
frequency of large expansions in the cerebellum, cerebrum, and
dorsal root ganglia, but not in heart or kidney. The absence of
Pms2 had no significant effect on contractions. Our results show
that while mammalian MMR promotes somatic instability of the
(GAA?TTC)n sequence, Pms2 plays a unique role in suppressing
large somatic expansions in neuronal tissues.
Materials and Methods
Transgenic mice, tissues and DNA samples
YG8 FXN GAA repeat expansion-containing transgenic mice
were crossed with Msh2, Msh6 or Pms2 heterozygous knockout
mice to establish double genetically modified mice as previously
described [47]. Genomic DNA was isolated from multiple tissues
of MMR-deficient and MMR-proficient YG8 mice using the
DNeasy Blood & Tissue Kit (Qiagen). We previously showed that
the YG8 mice developed substantial somatic instability by 10 to 12
months of age, and that instability was most marked in the
cerebellum [6]. In order to test the effect of MMR we therefore
collected tissues from mice at 10 to 12 months of age. Cerebellum
was analyzed for all genotypes, and other selected tissues were
analyzed as follows: 10-month old YG8-Msh2+/+ and YG8-
Msh22/2 (cerebellum, cerebrum, DRG, heart); 12-month old
YG8-Pms2+/+ and YG8-Pms22/2 (cerebellum, cerebrum, DRG,
heart, kidney); 5-month old YG8-Pms2+/+ and YG8-Pms22/2
(cerebellum); 11- or 12-month old YG8-Msh6+/+ and YG8-
Msh62/2 (cerebellum). The use of animals for this research
project was reviewed and approved by the Institutional Animal
Care and Use Committee at the University of Oklahoma Health
Sciences Center (protocol 08-129), and the Animal Ethics
Committee at Brunel University.
Small-pool PCR analysis
Small-pool PCR was performed as previously described [46,48].
Briefly, serial dilutions of DNA were made to obtain ‘‘small pools’’
of DNA containing 1–19 amplifiable molecules per reaction for
mutation load analysis, or 12–84 amplifiable molecules per
reaction for analysis of large expansions. The number of molecules
per reaction was calculated according to the Poisson distribution,
as previously described [46,48]. The repeat tract was amplified
using primers 147–For and 602-Rev [6]. Products were detected
by Southern blot analysis with an end-labeled (TTC)11 probe. The
sizes of the progenitor alleles were determined by conventional
PCR, and mutations were defined as length changes of .5% from
the progenitor. Mutation load was calculated as 1006 (total
PMS2 Suppresses Trinucleotide Repeat Expansion
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number of mutations)/(total molecules analyzed). As we have
previously described, the YG8 mice carry multiple copies of the
transgene, seen as multiple progenitor/constitutional allele lengths
[6] Therefore, expansions and contractions were conservatively
defined as products that measured .5% above the longest or
below the shortest constitutional allele, respectively. Mutations
that measured between the top and bottom progenitors were
classified as intermediate changes, since they could have resulted
from expansion of a shorter progenitor or contraction of a larger
progenitor. The size of an expansion was calculated as the percent
increase in length above the longest progenitor allele. Importantly,
all comparisons examined instability in the same tissue from wild-
type vs. knockout littermates of similar age, or from young vs. old
mice from the same line and genotype. In particular, the different
number of progenitor alleles and different progenitor allele lengths
of the YG8-Pms2+/+ and YG8-Pms22/2 lines vs. other lines would
confound comparisons between these and other lines. Since only
the bands that were longer than the longest progenitor allele were
considered expansions, the presence of more progenitor alleles
would reduce the apparent expansion load. Therefore, compar-
isons could not be made between different lines (e.g.,
YG8-Msh2+/+ vs. YG8-Pms2+/+).
Statistical analysis
Frequencies were compared by Chi-square test, and medians
were compared by Mann-Whitney U test. P,0.05 was considered
significant.
Results
Deficiency of MutSa reduces somatic instability and
prevalence of expansions of the expanded (GAA?TTC)n
sequence in neuronal tissues
We previously described tissue-specific, age-dependent somatic
instability in the YG8 transgenic mouse model carrying
(GAA?TTC)190 and (GAA?TTC)82 sequences in the context of
the human FXN locus [42]. Mice deficient in individual MMR
proteins were crossed onto the background of the YG8 transgenic
mouse to generate models for studying the effects of MMR on
instability of the expanded (GAA?TTC)n sequence. Small-pool
PCR was used to analyze instability in neuronal and non-neuronal
tissues in order to detect whether instability increased or decreased
in the absence of individual MMR proteins. Cerebellum,
cerebrum, and DRG were selected as representative neuronal
tissues, and heart and kidney were selected as non-neuronal
tissues. Products with repeat lengths that varied in length by more
than 5% from the progenitors were considered mutations (see
Materials and Methods). Multiple progenitor alleles were gener-
ated during the breeding process (e.g., note the three progenitor
alleles for Msh2 and Msh6 mice, indicated by arrowheads next to
each gel in Figure 1). Any mutation falling between progenitor
alleles could have resulted from expansion of a shorter progenitor
or contraction of a longer progenitor; such mutations could not be
definitively described as either expansions or contractions.
Therefore, expansions were conservatively defined as mutations
that were larger than the longest progenitor allele, and contrac-
tions were similarly defined as mutations that were smaller than
the shortest progenitor allele. Mutations that fell between the
longest and shortest progenitors were not classified as expansions
or contractions, but they were included in the calculation of the
total mutation load.
Consistent with our previously published results [6], the
prevalence of contractions in all YG8 transgenic mice was much
lower than the prevalence of expansions, with many tissues
showing no contractions (Tables 1 and 2). The absence of Msh2,
Msh6, or Pms2 did not increase the contraction load, indicating
that these MMR proteins do not suppress somatic contractions of
the (GAA?TTC)n sequence. We could not conclusively determine
whether the absence of Msh2 might result in a further decrease in
somatic contractions of the (GAA?TTC)n sequence, although any
such decrease is unlikely to be biologically relevant given the very
low levels of somatic contraction in all tissues analyzed. Based on
these data, we conclude that MMR does not affect somatic
contractions of the (GAA?TTC)n sequence. Finally, because of the
generally low prevalence of contractions, it is quite possible that
the unclassified mutations in our analyses are likely the result of
expansions from smaller progenitor alleles rather than contractions
from larger progenitor alleles.
The results of small-pool PCR analysis of the tissues from 10-
month old YG8-Msh2+/+ and YG8-Msh22/2 littermates are
shown in Figure 1 (A–D) and summarized in Table 1. In contrast,
Msh2 deficiency resulted in a significant and substantial decrease
in overall mutation load as well as expansion load in the
cerebellum and a significant decrease in overall mutation load in
cerebrum. In the heart and DRG, there were virtually no
expansions in either genotype, and the absence of Msh2 did not
further reduce the already low mutation load (P.0.05 in YG8-
Msh2+/+ vs. YG8-Msh22/2). Because Msh2 is required for
initiation of MMR, these results suggest that an active MMR
system may be required for somatic expansion of the (GAA?TTC)n
sequence.
To further investigate the role of the MMR system in promoting
instability of the expanded (GAA?TTC)n sequence, we analyzed
somatic instability in cerebellum of 11- to 12-month old YG8-
Msh6+/+ and YG8-Msh62/2 mice. The mutation load was also
significantly lower in the YG8-Msh62/2 versus YG8-Msh6+/+
littermates (Figure 1E–H and Table 1). Together these results
indicate that somatic expansion of the expanded (GAA?TTC)n
sequence, especially in cerebellum and cerebrum, is dependent on
MutSa.
Pms2 deficiency increases the frequency and magnitude
of (GAA?TTC)n expansions in neuronal tissues
Small-pool PCR analysis of somatic instability in tissues from
the 12-month old YG8-Pms2+/+ and YG8-Pms22/2 mice showed
that the absence of Pms2 did not significantly change the mutation
load in cerebellum, DRG, heart, or kidney, and only slightly
increased the mutation load in the cerebrum. However, Pms2
deficiency significantly increased the prevalence of expansions in
cerebrum (Figure 2, Table 2), cerebellum (Figure 3, Table 2) and
DRG (Table 2), but not in heart or kidney (Figure 4, Table 2). It is
interesting that the expansion frequency in the YG8-Pms2+/+
tissues is much lower than that in the YG8-Msh2+/+ and YG8-
Msh6+/+ tissues. This observation raises the possibility that the
increased expansion load observed in YG8-Pms22/2 tissues could
be an artifact of the low level of expansions in the wild-type.
However, we observed significant increases in expansion load in
both young and old YG8-Pms22/2 mice, and these data are
consistent with recently published results showing that the loss of
Pms2 specifically promotes expansions of repeat sequences,
including during intergenerational transmission of the
(GAA?TTC)n sequence [47] (see Discussion). Therefore, we
conclude that Pms2 may specifically prevent expansions of the
(GAA?TTC)n sequence in neuronal tissues.
Furthermore, Pms2 deficiency in the cerebrum significantly
increased the prevalence of large expansions, defined as those
.10% longer than the longest progenitor allele (Figure 2; 9.0% of
amplifiable molecules in YG8-Pms22/2 vs. 3.4% in YG8-Pms2+/+;
PMS2 Suppresses Trinucleotide Repeat Expansion
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P,0.05). In addition, while Pms2 deficiency did not affect the
prevalence of large expansions in other tissues, we did observe that
expansions exceeding the longest progenitor allele length by
.20% occurred only in the cerebellum (n= 7) and DRG (n=1) of
the Pms2 knockout, and not in the wild-type.
To further investigate the influence of Pms2 deficiency on the
prevalence of large expansions in the cerebellum and DRG, we
performed additional small-pool PCR experiments using ,80
amplifiable molecules per reaction to facilitate the detection of rare
large expansions. Analysis of .8,000 amplifiable molecules from
the cerebellum and .1,500 from the DRG revealed a significant
increase in the prevalence of large expansions in the absence of
Pms2 (Table 3). The absence of Pms2 also significantly changed
the size distribution of expansions in the cerebellum (Figure 5;
P,0.05). In the absence of Pms2, we observed a median
expansion size of 20.2% (P,0.005 compared to wild-type),
including expansions that were .40% longer than the longest
progenitor allele; in contrast, in the presence of Pms2, the median
expansion size was 14.8%, with no expansions of .40% and very
few expansions of .20%. Together, these data indicate that Pms2
suppresses large expansions of the (GAA?TTC)n sequence in
neuronal tissues.
Expansions of the (GAA?TTC)n sequence have been shown to
accumulate with age, both in humans [5,49] and in YG8 mice [6].
Therefore, to determine if Pms2 influenced the age-dependent
accumulation of expansions, we analyzed the prevalence of large
expansions in the cerebellum of 5-month old YG8-Pms2+/+ and
YG8-Pms22/2 mice (Table 3). Rare large expansions were already
present at 5 months of age in the knockout, but these were not
observed in the wild-type. The prevalence of large expansions was
significantly higher at 12 months of age (Table 3), suggesting that
Pms2 deficiency also influences the age-dependent rate of
accumulation of large expansions of the (GAA?TTC)n sequence
in the cerebellum.
Discussion
Consistent with previous studies on somatic instability of
trinucleotide repeats [7,18–22], our data also show that mamma-
lian MutS homologs are required for further somatic expansion of
the expanded (GAA?TTC)n sequence in transgenic mice. This
Figure 1. Absence of MutSa reduces somatic mutation load of the (GAA?TTC)n sequence. Panels A, B, E, and F show representative
autoradiographs from SP-PCR analysis of DNA extracted from (A) Msh2+/+, (B) Msh22/2, (E) Msh6+/+, and (F) Msh62/2 cerebellum. Progenitor allele
lengths determined by conventional PCR are 192, 130, and 89 repeats for Msh2+/+; 188, 128, and 88 repeats for Msh22/2; 186, 133, and 98 repeats for
Msh6+/+; and 187, 129, and 90 repeats for Msh62/2, as indicated by arrowheads at the right of each panel. Results from the total analysis of 150 to 282
molecules per genotype are quantified in C and D for Msh2, and G and H for Msh6.
doi:10.1371/journal.pone.0047085.g001
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observation is also consistent with the observation that expansion
of the (GAA?TTC)n sequence in induced pluripotent stem cells
(iPSCs) derived from fibroblasts of Friedreich ataxia patients was
dependent on Msh2 [50]. Our analysis did not directly assess the
role of MutSb in somatic instability, since the effects of Msh3 were
not determined. Our data specifically point to a role for MutSa in
somatic expansions, but this does not exclude the possibility that
MutSb participates in somatic instability of the expanded
(GAA?TTC)n sequence.
Mismatch repair proteins may act on a lesion or secondary
structure of the (GAA?TTC)n sequence that predominantly occurs
in neuronal tissues, since instability in non-neuronal tissues was not
affected by Msh2, Msh6, or Pms2. Triplexes, R-loops and/or
DNA double strand breaks (DSBs) are likely candidates. The
(GAA?TTC)n sequence is known to form Y?R?Y triplexes under
physiologically relevant conditions [40]. Triplex structures have
been shown to promote replication stalling [51], which is known to
promote DSB formation [52], and evidence suggests that
recombinases may preferentially target expanded (GAA?TTC)n




Load, % (P)* Contractionsˆ
Contraction
Load, % (P)* Total Mutationsˆ
Mutation
Load, % (P)*
Msh2 +/+ (10 month)
Cerebellum 166 24 14.5 1 0.6 70 42.2
Cerebrum 416 9 2.2 2 0.5 21 5.0
Dorsal Root Ganglia 254 1 0.4 1 0.4 11 4.3
Heart 201 0 0 1 3.7 4 2.0
Msh2 2/2 (10 month)
Cerebellum 282 1 0.4 (,0.01) 5 1.8 18 6.4 (,0.01)
Cerebrum 160 0 0 0 0 2 1.2 (,0.05)
Dorsal Root Ganglia 306 2 0.7 2 0.7 9 2.9
Heart 123 2 1.6 1 0.8 3 2.4
Msh6 +/+ (11 month)
Cerebellum 150 24 16.0 13 8.7 74 49.3
Msh6 2/2 (12 month)
Cerebellum 201 6 3.0 (,0.01) 8 4.0 29 14.4 (,0.01)
*P values indicate statistical significance between +/+ and 2/2. P values are not indicated when not significant.
Bˆecause multiple progenitor alleles were present, changes between progenitors could not be definitively identified as contractions or expansions. Contractions and
expansions were conservatively defined as molecules that were at least 5% shorter than the smallest progenitor or 5% longer than the largest progenitor, respectively.
Contractions, expansions, and changes between progenitors were included in ‘‘Total Mutations’’.
doi:10.1371/journal.pone.0047085.t001




Load, % (P)* Contractionsˆ
Contraction
Load, % (P)* Total Mutationsˆ
Mutation
Load, % (P)*
Pms2 +/+ (12 month)
Cerebellum 405 14 3.5 13 3.2 94 23.2
Cerebrum 581 27 4.6 4 0.7 89 15.3
Dorsal Root Ganglia 616 0 0 3 0.5 13 2.1
Heart 117 0 0 1 0.9 2 1.7
Kidney 569 1 0.2 0 0 1 0.2
Pms2 2/2 (12 month)
Cerebellum 451 31 6.9 (,0.05) 8 1.8 107 23.7
Cerebrum 543 49 9.0 (,0.01) 2 0.4 122 22.5 (,0.01)
Dorsal Root Ganglia 666 5 0.8 (,0.05) 0 0 13 2.0
Heart 263 0 0 0 0 5 1.9
Kidney 364 1 0.3 0 0 1 0.3
*P values indicate statistical significance between +/+ and 2/2. P values are not indicated when not significant.
Bˆecause multiple progenitor alleles were present, changes between progenitors could not be definitively identified as contractions or expansions. Contractions and
expansions were conservatively defined as molecules that were at least 5% shorter than the smallest progenitor or 5% longer than the largest progenitor, respectively.
Contractions, expansions, and changes between progenitors were included in ‘‘Total Mutations’’.
doi:10.1371/journal.pone.0047085.t002
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Figure 2. Absence of Pms2 increases somatic expansion load of the (GAA?TTC)n sequence in cerebrum. Analysis of instability in
cerebrum of Pms2+/+ and Pms22/2 mice. Representative autoradiographs from (A) Pms2+/+ and (B) Pms22/2 cerebrum are shown. Progenitor allele
lengths of 229, 194, 135, and 94 repeats for Pms2+/+ and 229, 185, 130, and 86 repeats for Pms22/2 are indicated by arrowheads at the right of each
panel. Mutation load and expansion load, quantified from the analysis of ,550 molecules per genotype, are shown in panels C and D, respectively.
Panels E and F indicate the distribution of repeat lengths for all SP-PCR products of (E) Pms2+/+ and (F) Pms22/2. These graphs are therefore an exact,
combined representation of all blots analyzed for Pms2+/+ and Pms22/2 cerebrum. The number of products measured at each repeat length is on the
Y-axis. Note that the actual frequency of products at the progenitor lengths may be slightly higher than the counted frequency, because a single
band may represent PCR products amplified from multiple progenitor molecules. The gray bands represent the progenitor allele lengths +/25%.
Lines within the gray bands represent unchanged bands. Lines outside of these ranges represent mutations. Those to the right of the rightmost band
represent expansions, those to the left of the leftmost band represent contractions, and those in the middle represent unclassified mutations. Panel G
shows the cumulative number of products observed with increasing expansion size. Expansion size was calculated as the percent increase in repeat
length above the largest progenitor. An incremental increase is seen in Pms22/2 versus Pms2+/+ mice at all expansion sizes, but the increase in
magnitude of the difference at higher expansion sizes points to the role of Pms2 in preferentially suppressing large expansions in the cerebrum.
doi:10.1371/journal.pone.0047085.g002
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Figure 3. Absence of Pms2 increases somatic expansion load of the (GAA?TTC)n sequence in cerebellum. Analysis of instability in
cerebellum of Pms2+/+ and Pms22/2 mice. Progenitor allele lengths of 232, 199, 143, and 99 repeats for (A) Pms2+/+, and 224, 195, 152, and 101
repeats for (B) Pms22/2 are indicated by arrowheads. Mutation load and expansion load, calculated from analysis of ,400 molecules per genotype,
are shown in C and D, respectively. Panels E and F indicate the distribution of repeat lengths for all SP-PCR products of (E) Pms2+/+ and (F) Pms22/2.
These graphs are therefore an exact, combined representation of all blots analyzed for Pms2+/+ and Pms22/2 cerebrum. The number of products
measured at each repeat length is on the Y-axis. Note that the actual frequency of products at the progenitor lengths may be slightly higher than the
counted frequency, because a single band may represent PCR products amplified from multiple progenitor molecules. The gray bars represent the
progenitor allele lengths +/25%. Lines within the gray bands represent unchanged bands. Lines outside of these ranges represent mutations. Those
to the right of the rightmost band represent expansions, those to the left of the leftmost band represent contractions, and those in the middle
represent unclassified mutations. Products outside of these ranges were counted as mutations. Panel G shows the cumulative number of products
observed with increasing expansion size. Expansion size was calculated as the percent increase in repeat length above the largest progenitor. An
incremental increase is seen in Pms22/2 versus Pms2+/+ mice at all expansion sizes, but the increase in magnitude of the difference at higher
expansion sizes points to the role of Pms2 in preferentially suppressing large expansions in the cerebellum.
doi:10.1371/journal.pone.0047085.g003
PMS2 Suppresses Trinucleotide Repeat Expansion
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sequences in a Y?R?Y formation [53]. Similarly, R-loops, in which
the nascent transcript forms a duplex with the transcriptional
template strand, are mutagenic structures that can result in DSBs
and recombination via TAR (transcription associated recombina-
tion) [54]. R-loops do not normally form during transcription
because the nascent transcript is prevented from interacting with
the template DNA. However, R-loop formation is known to occur
when the (GAA?TTC)n sequence is transcribed [55], and multiple
observations suggest that R-loops may be involved in the
expansion process. First, with increasing or decreasing transcrip-
tion of the (GAA?TTC)n sequence in cultured human cells,
somatic instability and expansions also increase or decrease,
respectively [56,57]. In addition, data from cultured primate cells
implicate a direct role for the GAA-containing transcript in
causing expansions of the (GAA?TTC)n sequence [58]. Therefore,
factors that regulate somatic expansion of the (GAA?TTC)n
sequence could do so by influencing the formation and/or
resolution of R-loop formation
Several factors promote R-loop formation, such as defective
biogenesis of messenger ribonucleoprotein (mRNP) particles,
deficiency of proteins responsible for splicing and/or nuclear
export of transcripts, and sequence composition of the non-
template strand [54]. For instance, human cells deficient in the
ASF/SF2 splicing factor are prone to R-loop formation and DSBs
[59]. In addition, both transcription and G-rich sequences, which
adopt a G-quartet structure on the non-template strand, facilitate
Figure 4. Absence of Pms2 does not affect somatic instability of the (GAA?TTC)n sequence in non-neuronal tissues. Panels show the
distribution of repeat lengths measured in (A,B) heart and (C,D) kidney from (A,C) Pms2+/+ and (B,D) Pms22/2 littermates. The number of products
measured at each repeat length is on the Y-axis. Gray bars represent the length of the progenitor alleles, +/25%. Products that fell outside of these
ranges were considered mutations.
doi:10.1371/journal.pone.0047085.g004
Figure 5. Absence of Pms2 results in larger expansions of the
(GAA?TTC)n sequence in cerebellum. SP-PCR was performed using
approximately 80 molecules per reaction to detect rare large
expansions. Expansion sizes were calculated as the percent increase,
of number of repeats, from the longest progenitor. Expansions of at
least 10% were considered large expansions. The size distribution of
large expansions was significantly different between Pms2+/+ and
Pms22/2 cerebellum (P,0.05).
doi:10.1371/journal.pone.0047085.g005
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R-loop formation in the switch regions of immunoglobulin (Ig)
genes, a requirement for intrachromosomal class switch recombi-
nation during antibody isotype switching in mature B cells [60].
The R-loop structure predicted for the transcribed (GAA?TTC)n
sequence involves the nascent GAA-containing transcript forming
an R-loop structure with the TTC-containing template strand,
which would result in a segment of single-stranded non-template
strand [55]. This GAA-containing stand would be expected to
adopt one or more metastable secondary structures, as the single-
stranded GAA sequence is known to do [61], and the very low
affinity of polypurine sequences for the eukaryotic single-strand
binding protein (replication protein A) [62], would be expected to
exacerbate secondary structure formation. In this regard, the R-
loops formed during transcription of the (GAA?TTC)n sequence
would be similar to those promoted by the G-rich sequences in Ig
class switch recombination. In addition, like the R-loops formed in
Ig genes, it is possible that one or more of the abnormal structures
of the non-template GAA strand could be recognized by MutS
homologs, leading to error prone repair. This model is consistent
with the observation made by Ku and colleagues, who demon-
strated that Msh2 binds in or near the expanded (GAA?TTC)n
sequence in vivo in iPSCs derived from Friedreich ataxia patients
[50].
If the R-loop or triplex structures results in a DSB, as in Ig class
switch recombination and in cells deficient in ASF/SF2 splicing
factor, then expansions of the (GAA?TTC)n sequence could occur
via MMR proteins contributing to error-prone DSB repair. DSB
repair, via both the non-homologous end-joining and homologous
recombination pathways, is known to occur in neurons and the
postnatal brain [63,64]. Indeed, given the extensive complemen-
tarity across the expanded (GAA?TTC)n tract, and its propensity
to adopt secondary structures, DSB repair within the expanded
(GAA?TTC)n sequence is known to be highly error-prone, with
misalignments contributing to repeat instability [65]. It is also
noteworthy that the DNA breaks during class switch recombina-
tion in B cells actually occur in the G1 phase and are dependent
upon MMR [66]. Thus, MutS-initiated error prone repair of
secondary structures or DSBs could explain the reduced levels of
somatic expansions observed in the mice deficient in MutS
homologs.
As part of the MutLa complex, Pms2 links mismatch
recognition by MutS homologs to the downstream steps in
MMR. Therefore, if the canonical MMR pathway affects somatic
instability of (GAA?TTC)n sequences, Pms2 would be expected to
have an effect on repeat instability similar to that of the MutS
homologs. Indeed, the absence of Pms2 reduced the rate of
expansion of the (CAG?CTG)n sequence in transgenic mice by
,50% [24]. Paradoxically, our results indicate that the absence of
Pms2 actually increases the prevalence of large expansions of the
(GAA?TTC)n sequence in neuronal tissues, which contrasts with
the dramatic reduction of somatic expansions caused by the
absence of MutS homologs. The exact reason for this difference is
unclear; however, it is noteworthy that Pms2 has also been shown
to suppress expansions of other non-hairpin-forming microsatellite
repeats, albeit in disparate assays that involved shorter tracts. For
instance, in Pms2-null human cell lines, a plasmid-based assay
showed a higher percentage of length mutations involving small
expansions rather than contractions of the (TTCC?GGAA)9
sequence [67]. Similarly, at three different mouse loci containing
(CA)n repeats, the absence of Pms2 produced instability that was
biased toward expansions in somatic tissues, although these
expansions only consisted of small gains [68]. It is interesting to
note that the (TTCC?GGAA)n sequence forms a polypurine?po-
lypyrimidine tract similar to the (GAA?TTC)n sequence whereas
the (CA)n repeat does not. Indeed, intergenerational transmission
of the expanded (GAA?TTC)n sequence by Pms2 null mice led to
expansions in the offspring in the majority of transmissions, and
this skewing towards expansions was not seen in mice deficient in
other MMR proteins [47]. Taken together, these data tend to
support a broader role for Pms2 in the prevention of expansion
mutations involving a variety of microsatellite repeats, and possibly
independent of its role in the MMR pathway.
How Pms2 prevents the accumulation of large expansions in
neuronal tissues remains unclear; however, it is plausible that this
may occur via its ability to act independently of Msh2 in
suppressing homologous recombination [69]. It is conceivable that
the deficiency of Pms2, and thereby its ability to suppress
homologous recombination, could result in large expansions of
the (GAA?TTC)n sequence via skewing of the repair mechanism
employed for DSB repair (Figure 6). This model would be
consistent with the differential effects of Pms2 and MutSa
deficiency on the expanded (GAA?TTC)n sequence we observed.
It is unclear why the accumulation of mutations varies
substantially among different regions of the nervous system.
Potential contributing factors include the distinct variability of cell
types composing various regions of the nervous system, differential
Table 3. Effect of Pms2 on large expansions in cerebellum and DRG.
Molecules Analyzed Large Expansions Large Expansion Load, % (P)*
Pms2 +/+ (12 month)
Cerebellum 4399 32 0.7
Dorsal Root Ganglia 780 1 0.1
Pms2 2/2 (12 month)
Cerebellum 3985 114 2.9 (,0.001)
Dorsal Root Ganglia 876 10 1.1 (,0.05)
Pms2 +/+ (5 month)
Cerebellum 624 0 0
Pms2 2/2 (5 month)
Cerebellum 907 6 0.7 (,0.05)
*P values indicate statistical significance between +/+ and 2/2.
P values are not indicated when not significant.
doi:10.1371/journal.pone.0047085.t003
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prevalence of triplexes, R-loops and DSBs, and differential activity
and fidelity of DNA repair mechanisms. Indeed, DNA repair
activity varies between different regions of the brain [64]. In
addition, cellular DSBs, which are usually efficiently repaired in
somatic cells to permit cell survival [70], are known to accumulate
in postmitotic neurons in an age-dependent manner [71]. These
changes could thus allow for the age-dependent accumulation of
expansions in specific components of the nervous system.
Furthermore, the expanded (GAA?TTC)n sequence became more
unstable during intergenerational transmission [47], as opposed to
the enhanced stability we observed in somatic tissues of Msh2 and
Msh6 null mice. This, and the age-dependent accumulation of
mutations in somatic tissues, suggests that the mechanism of
expansion and contraction of the (GAA?TTC)n sequence are
different in somatic and germ cells.
The progressive expansion of the (GAA?TTC)n sequence in the
FXN gene in DRG and cerebellum of Friedreich ataxia patients
may play a role in influencing the tissue-specific pathogenesis of
this disease [5]. Furthermore, the progressive expansion of
relatively short alleles within the expanded range may influence
the development of mild, late-onset Friedreich ataxia [72].
Therefore, the finding that Pms2 prevents large expansions of
the (GAA?TTC)n sequences in neuronal tissues is particularly
exciting. Given this unique role, it is tempting to speculate that
Pms2 may serve as a genetic modifier of the disease phenotype in
Friedreich ataxia.
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